Cargando…

Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis

BACKGROUND: This study identified the risk factors for survival in patients with primary central nervous system lymphoma (PCNSL). Nomograms were developed and validated to predict individualized overall survival (OS) and cancer-specific survival (CSS) in this particular cohort. METHODS: Patients dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chuanwei, Ren, Xiaohui, Cui, Yong, Jiang, Haihui, Yu, Kefu, Li, Mingxiao, Zhao, Xuzhe, Zhu, Qinghui, Lin, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339814/ https://www.ncbi.nlm.nih.gov/pubmed/34422967 http://dx.doi.org/10.21037/atm-21-753

Ejemplares similares

Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
por: Yang, Chuanwei, et al.
Publicado: (2022)

Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study
por: Jiang, Haihui, et al.
Publicado: (2021)

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma
por: Jiang, Haihui, et al.
Publicado: (2021)

Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications
por: Jiang, Haihui, et al.
Publicado: (2020)

Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma
por: Li, Mingxiao, et al.
Publicado: (2021)

A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma
por: Zhu, Qinghui, et al.
Publicado: (2022)

Characterization and clinical implications of different malignant transformation patterns in diffuse low‐grade gliomas
por: Jiang, Haihui, et al.
Publicado: (2023)

Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas
por: Li, Mingxiao, et al.
Publicado: (2022)

T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination
por: Li, Mingxiao, et al.
Publicado: (2022)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
por: Wu, H. G., et al.
Publicado: (1999)

MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)

Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009
por: Shin, Sang-Hoon, et al.
Publicado: (2015)

Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study
por: Shan, Yudong, et al.
Publicado: (2018)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

Extent of radiological response does not reflect survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)

Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020)

Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
por: Puhakka, Inka, et al.
Publicado: (2022)

Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study
por: Chi, Kaiyi, et al.
Publicado: (2023)

Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma
por: Lin, Junyi, et al.
Publicado: (2022)

Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?
por: Matsuo, Toshihiko, et al.
Publicado: (2019)

Mutational analysis of primary central nervous system lymphoma
por: Bruno, Aurélie, et al.
Publicado: (2014)

Unusual relapse of primary central nervous system lymphoma
por: Igala, Marielle
Publicado: (2016)

Radiation Therapy for Primary Central Nervous System Lymphoma
por: Shibamoto, Yuta
Publicado: (2013)

Primary cardiac lymphoma with central nervous system relapse
por: van Rooijen, Cleo R., et al.
Publicado: (2017)

Advances in Pathobiology of Primary Central Nervous System Lymphoma
por: Yang, Xue-Liang, et al.
Publicado: (2017)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Primary peripheral T-cell central nervous system lymphoma
por: Bird, Cylaina E., et al.
Publicado: (2021)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling
por: Alame, Melissa, et al.
Publicado: (2021)

Second-line treatment for primary central nervous system lymphoma
por: Reni, M, et al.
Publicado: (1999)

Masquerade Syndrome of Multicentre Primary Central Nervous System Lymphoma
por: Guerriero, Silvana, et al.
Publicado: (2011)

Near Misdiagnosis of Glioblastoma as Primary Central Nervous System Lymphoma
por: Bhatt, Vijaya Raj, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i980tas13j3goor1aij38tidgi